It has been a tough few years for European med-tech companies but the tide seems to be turning in 2025. BioWorld garnered the views of leading investors and several companies on the coming year. Public markets are reopened, investors have capital to deploy and corporates are on the hunt for devices that address unmet clinical needs. Although some companies remain concerned about the environment, many more are positive. With funds to raise, clinical trials to conduct and products to launch, the sentiment overall is certainly bullish.

Sofinnova raises €1.2B to invest in med tech, biotech, digital health
March 4, 2025

Resurging med tech set to thrive in Europe
Feb. 27, 2025

Cardiovascular, robotics and AI attract European VCs
Feb. 19, 2025

European VCs bullish on med-tech investments in 2025
Feb. 13, 2025

European VCs optimistic for med-tech exit opportunities in 2025
Feb. 6, 2025